Goat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer) (ab2891)
Key features and details
- Goat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer)
- Conjugation: HRP polymer
- Host species: Goat
- Isotype: IgG
- Suitable for: IHC-P, IHC-Fr
Overview
-
Product name
Goat Anti-Mouse Anti-Rabbit IgG/IgM H&L (HRP polymer)
See all IgG + IgM secondary antibodies -
Host species
Goat -
Target species
Mouse -
Specificity
This antibody reacts with heavy and light chains on mouse and rabbit IgG. It reacts with all mouse and rabbit IgG subclasses and with mouse and rabbit IgM. -
Tested applications
Suitable for: IHC-P, IHC-Frmore details -
Conjugation
HRP polymer
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
Constituents: 0.04% Proclin 300, 0.5% Proclin 950, 99% Water -
Concentration information loading...
-
Conjugation notes
HRP conjugated to a polymer backbone, which is collectively conjugated to the antibody. The effect is multiple HRP molecules linked to one single antibody. -
Clonality
Polyclonal -
Isotype
IgG -
General notes
This new and innovative HRP-polymerization technology provides a significant increase in staining sensitivity when compared to other conventional HRP-conjugated secondary antibodies. Avidin-biotin blocking procedures are not necessary when using this product. The overall staining procedure uses one less reagent (streptavidin peroxidase) and rinsing step, eliminates avidin-biotin blocking procedures and may reduce overall staining time.
-
Research areas
Associated products
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab2891 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
IHC-P |
Use at an assay dependent dilution.
|
|
IHC-Fr |
Use at an assay dependent dilution. This product is provided in a pre-diluted, ready-to-use format. Apply for 20 - 30 minutes.
|
Notes |
---|
IHC-P
Use at an assay dependent dilution. |
IHC-Fr
Use at an assay dependent dilution. This product is provided in a pre-diluted, ready-to-use format. Apply for 20 - 30 minutes. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (21)
ab2891 has been referenced in 21 publications.
- Xin Z et al. The immune landscape of human thymic epithelial tumors. Nat Commun 13:5463 (2022). PubMed: 36115836
- Hashemibeni B et al. Investigation and Comparison of the Effect of TGF-ß3, kartogenin and Avocado/Soybean Unsaponifiables on the In-vitro and In-vivo Chondrogenesis of Human Adipose-Derived Stem Cells on Fibrin Scaffold. Iran J Pharm Res 20:368-380 (2021). PubMed: 34903995
- Zhao Z et al. Gut Microbiota Was Involved in the Process of Liver Injury During Intra-Abdominal Hypertension. Front Physiol 12:790182 (2021). PubMed: 34955896
- Feng C et al. Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma. Mol Ther Nucleic Acids 20:186-195 (2020). PubMed: 32169806
- Hadziselimovic F et al. Abnormal histology in testis from prepubertal boys with monorchidism. Basic Clin Androl 30:11 (2020). PubMed: 32782807